Dysfunctional Dopaminergic Neurones in Mouse Models of Huntington's Disease: A Role for SK3 Channels
Authors:
- Grégoire LevasseurGLGrégoire Levasseur
- Sarat C. VatsavayaiSVSarat C. Vatsavayai
- Austen J. MilnerwoodAMAusten J. Milnerwood
- Damian M. CummingsDCDamian M. Cummings
- Igor KraevIKIgor Kraev
- Chloé HuetzCHChloé Huetz
- Karen A. EvansKEKaren A. Evans
- Steve W. WaltersSWSteve W. Walters
- Payam RezaiePRPayam Rezaie
- Yoon ChoYCYoon Cho
- Mark C. HirstMHMark C. Hirst
- 1 April 2015
- journal article
- research article
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 15 (2) , 93-108
Abstract
Background: Huntington's disease (HD) is a late-onset fatal neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the gene coding for the protein huntingtin and is characterised by progressive motor, psychiatric and cognitive decline. We previously demonstrated that normal synaptic function in HD could be restored by application of dopamine receptor agonists, suggesting that changes in the release or bioavailability of dopamine may be a contributing factor to the disease process. Objective: In the present study, we examined the properties of midbrain dopaminergic neurones and dopamine release in presymptomatic and symptomatic transgenic HD mice. Methods and Results: Using intracellular sharp recordings and immunohistochemistry, we found that neuronal excitability was increased due to a loss of slow afterhyperpolarisation and that these changes were related to an apparent functional loss and abnormal distribution of SK3 channels (KCa2.3 encoded by the KCNN3 gene), a class of small-conductance calcium-activated potassium channels. Electrochemical detection of dopamine showed that this observation was associated with an enhanced dopamine release in presymptomatic transgenic mice and a drastic reduction in symptomatic animals. These changes occurred in the context of a progressive expansion in the CAG repeat number and nuclear localisation of mutant protein within the substantia nigra pars compacta. Conclusions: Dopaminergic neuronal dysfunction is a key early event in HD disease progression. The initial increase in dopamine release appears to be related to a loss of SK3 channel function, a protein containing a polyglutamine tract. Implications for polyglutamine-mediated sequestration of SK3 channels, dopamine-associated DNA damage and CAG expansion are discussed in the context of HD.Keywords
This publication has 75 references indexed in Scilit:
- Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington diseaseProceedings of the National Academy of Sciences, 2011
- Impaired dopamine release and uptake in R6/1 Huntington's disease model miceNeuroscience Letters, 2011
- Differential Electrophysiological Changes in Striatal Output Neurons in Huntington's DiseaseJournal of Neuroscience, 2011
- Corticostriatal circuit dysfunction in Huntington‘s disease: intersection of glutamate, dopamine and calciumFuture Neurology, 2010
- Neurons Efficiently Repair Glutamate-induced Oxidative DNA Damage by a Process Involving CREB-mediated Up-regulation of Apurinic Endonuclease 1Journal of Biological Chemistry, 2010
- Dopamine and Glutamate in Huntington's Disease: A Balancing ActCNS Neuroscience & Therapeutics, 2010
- Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunctionHuman Molecular Genetics, 2010
- Mutant Huntingtin reduces HSP70 expression through the sequestration of NF‐Y transcription factorThe EMBO Journal, 2008
- OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cellsNature, 2007
- Apamin-sensitive Ca2+-activated K+ channels regulate pacemaker activity in nigral dopamine neuronsNeuroReport, 1996